This study aims to evaluate the safety and clinical efficacy of umbilical cord mesenchymal stem cell transplantation for decompensated hepatitis B cirrhosis.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
UC-MSC infusion by introvenus
Haikou People's Hospital
Haikou, China
RECRUITINGNumber of Participants with abnormal Total bilirubin
Time frame: Changes from baseline to 72 weeks
Number of Participants with abnormal albumin
Time frame: Changes from baseline to 72 weeks
Ishak Inflammation Rating System
Time frame: Changes from baseline to 72 weeks
Ishak Fibrosis Score
Time frame: Changes from baseline to 72 weeks
Overall survival (OS)
Time frame: Changes from baseline to 72 weeks
HBV-DNA
Time frame: Changes from baseline to 72 weeks
incidence of liver cancer
Time frame: Changes from baseline to 72 weeks
Number of Participants with abnormal immunoglobulin
Time frame: Changes from baseline to 72 weeks
portal vein flow rate
Time frame: Changes from baseline to 72 weeks
portal vein width
Time frame: Changes from baseline to 72 weeks
abdominal volume
Time frame: Changes from baseline to 72 weeks
Number of Participants with abnormal coagulation function
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Changes from baseline to 72 weeks